2022-03-012023-02-282023-02-28false13230371BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED2023-10-0685600iso4217:GBPxbrli:pure132303712022-03-01132303712023-02-28132303712022-03-012023-02-28132303712021-02-26132303712022-02-28132303712021-02-262022-02-2813230371bus:SmallEntities2022-03-012023-02-2813230371bus:AuditExempt-NoAccountantsReport2022-03-012023-02-2813230371bus:FullAccounts2022-03-012023-02-2813230371bus:PrivateLimitedCompanyLtd2022-03-012023-02-2813230371core:WithinOneYear2023-02-2813230371core:AfterOneYear2023-02-2813230371core:WithinOneYear2022-02-2813230371core:AfterOneYear2022-02-2813230371core:ShareCapital2023-02-2813230371core:SharePremium2023-02-2813230371core:RevaluationReserve2023-02-2813230371core:OtherReservesSubtotal2023-02-2813230371core:RetainedEarningsAccumulatedLosses2023-02-2813230371core:ShareCapital2022-02-2813230371core:SharePremium2022-02-2813230371core:RevaluationReserve2022-02-2813230371core:OtherReservesSubtotal2022-02-2813230371core:RetainedEarningsAccumulatedLosses2022-02-2813230371core:LandBuildings2023-02-2813230371core:PlantMachinery2023-02-2813230371core:Vehicles2023-02-2813230371core:FurnitureFittings2023-02-2813230371core:OfficeEquipment2023-02-2813230371core:NetGoodwill2023-02-2813230371core:IntangibleAssetsOtherThanGoodwill2023-02-2813230371core:ListedExchangeTraded2023-02-2813230371core:UnlistedNon-exchangeTraded2023-02-2813230371core:LandBuildings2022-02-2813230371core:PlantMachinery2022-02-2813230371core:Vehicles2022-02-2813230371core:FurnitureFittings2022-02-2813230371core:OfficeEquipment2022-02-2813230371core:NetGoodwill2022-02-2813230371core:IntangibleAssetsOtherThanGoodwill2022-02-2813230371core:ListedExchangeTraded2022-02-2813230371core:UnlistedNon-exchangeTraded2022-02-2813230371core:LandBuildings2022-03-012023-02-2813230371core:PlantMachinery2022-03-012023-02-2813230371core:Vehicles2022-03-012023-02-2813230371core:FurnitureFittings2022-03-012023-02-2813230371core:OfficeEquipment2022-03-012023-02-2813230371core:NetGoodwill2022-03-012023-02-2813230371core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2813230371core:ListedExchangeTraded2022-03-012023-02-2813230371core:UnlistedNon-exchangeTraded2022-03-012023-02-2813230371core:MoreThanFiveYears2022-03-012023-02-2813230371core:Non-currentFinancialInstruments2023-02-2813230371core:Non-currentFinancialInstruments2022-02-2813230371dpl:CostSales2022-03-012023-02-2813230371dpl:DistributionCosts2022-03-012023-02-2813230371dpl:AdministrativeExpenses2022-03-012023-02-2813230371core:LandBuildings2022-03-012023-02-2813230371core:PlantMachinery2022-03-012023-02-2813230371core:Vehicles2022-03-012023-02-2813230371core:FurnitureFittings2022-03-012023-02-2813230371core:OfficeEquipment2022-03-012023-02-2813230371core:NetGoodwill2022-03-012023-02-2813230371core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2813230371dpl:GroupUndertakings2022-03-012023-02-2813230371dpl:ParticipatingInterests2022-03-012023-02-2813230371dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2813230371core:ListedExchangeTraded2022-03-012023-02-2813230371dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2813230371core:UnlistedNon-exchangeTraded2022-03-012023-02-2813230371dpl:CostSales2021-02-262022-02-2813230371dpl:DistributionCosts2021-02-262022-02-2813230371dpl:AdministrativeExpenses2021-02-262022-02-2813230371core:LandBuildings2021-02-262022-02-2813230371core:PlantMachinery2021-02-262022-02-2813230371core:Vehicles2021-02-262022-02-2813230371core:FurnitureFittings2021-02-262022-02-2813230371core:OfficeEquipment2021-02-262022-02-2813230371core:NetGoodwill2021-02-262022-02-2813230371core:IntangibleAssetsOtherThanGoodwill2021-02-262022-02-2813230371dpl:GroupUndertakings2021-02-262022-02-2813230371dpl:ParticipatingInterests2021-02-262022-02-2813230371dpl:GroupUndertakingscore:ListedExchangeTraded2021-02-262022-02-2813230371core:ListedExchangeTraded2021-02-262022-02-2813230371dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-02-262022-02-2813230371core:UnlistedNon-exchangeTraded2021-02-262022-02-2813230371core:NetGoodwill2023-02-2813230371core:IntangibleAssetsOtherThanGoodwill2023-02-2813230371core:LandBuildings2023-02-2813230371core:PlantMachinery2023-02-2813230371core:Vehicles2023-02-2813230371core:FurnitureFittings2023-02-2813230371core:OfficeEquipment2023-02-2813230371core:AfterOneYear2023-02-2813230371core:WithinOneYear2023-02-2813230371core:ListedExchangeTraded2023-02-2813230371core:UnlistedNon-exchangeTraded2023-02-2813230371core:ShareCapital2023-02-2813230371core:SharePremium2023-02-2813230371core:RevaluationReserve2023-02-2813230371core:OtherReservesSubtotal2023-02-2813230371core:RetainedEarningsAccumulatedLosses2023-02-2813230371core:NetGoodwill2022-02-2813230371core:IntangibleAssetsOtherThanGoodwill2022-02-2813230371core:LandBuildings2022-02-2813230371core:PlantMachinery2022-02-2813230371core:Vehicles2022-02-2813230371core:FurnitureFittings2022-02-2813230371core:OfficeEquipment2022-02-2813230371core:AfterOneYear2022-02-2813230371core:WithinOneYear2022-02-2813230371core:ListedExchangeTraded2022-02-2813230371core:UnlistedNon-exchangeTraded2022-02-2813230371core:ShareCapital2022-02-2813230371core:SharePremium2022-02-2813230371core:RevaluationReserve2022-02-2813230371core:OtherReservesSubtotal2022-02-2813230371core:RetainedEarningsAccumulatedLosses2022-02-2813230371core:NetGoodwill2021-02-2613230371core:IntangibleAssetsOtherThanGoodwill2021-02-2613230371core:LandBuildings2021-02-2613230371core:PlantMachinery2021-02-2613230371core:Vehicles2021-02-2613230371core:FurnitureFittings2021-02-2613230371core:OfficeEquipment2021-02-2613230371core:AfterOneYear2021-02-2613230371core:WithinOneYear2021-02-2613230371core:ListedExchangeTraded2021-02-2613230371core:UnlistedNon-exchangeTraded2021-02-2613230371core:ShareCapital2021-02-2613230371core:SharePremium2021-02-2613230371core:RevaluationReserve2021-02-2613230371core:OtherReservesSubtotal2021-02-2613230371core:RetainedEarningsAccumulatedLosses2021-02-2613230371core:AfterOneYear2022-03-012023-02-2813230371core:WithinOneYear2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:CostValuation2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-012023-02-2813230371core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2813230371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:CostValuation2022-02-2813230371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-2813230371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-2813230371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-2813230371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-2813230371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-2813230371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-2813230371bus:Director12022-03-012023-02-28

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED

Registered Number
13230371
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2023

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Company Information
for the year from 1 March 2022 to 28 February 2023

Director

G Forrester

Registered Address

179 Park Lane
Poynton
SK12 1RH

Registered Number

13230371 (England and Wales)
BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Balance Sheet as at
28 February 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets7810-
810-
Current assets
Debtors-915
Cash at bank and on hand17,944831
17,9441,746
Creditors amounts falling due within one year9(13,221)(10,600)
Net current assets (liabilities)4,723(8,854)
Total assets less current liabilities5,533(8,854)
Net assets5,533(8,854)
Capital and reserves
Called up share capital100100
Profit and loss account5,433(8,954)
Shareholders' funds5,533(8,854)
The financial statements were approved and authorised for issue by the Director on 6 October 2023, and are signed on its behalf by:
G Forrester
Director
Registered Company No. 13230371
BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Notes to the Financial Statements
for the year ended 28 February 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Fixtures and fittings20
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Taxation policy
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
4.Critical estimates and judgements
In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
5.Sources of estimation uncertainty
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
6.Employee information

20232022
Average number of employees during the year11
7.Property, plant and equipment

Office Equipment

Total

££
Cost or valuation
Additions900900
At 28 February 23900900
Depreciation and impairment
Charge for year9090
At 28 February 239090
Net book value
At 28 February 23810810
At 28 February 22--
8.Debtors within one year

2023

2022

££
Other debtors-915
Total-915
Short term trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
9.Creditors within one year

2023

2022

££
Taxation and social security5,009-
Other creditors8,21210,600
Total13,22110,600
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.